UNSPSC 51391610: Aminophylline dihydrate

This classification denotes the dihydrate form of a phosphodiesterase inhibitor and bronchodilator with the molecular formula 2C7H8N4O2.C2H8N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 27Y3KJK423, chemically known as 3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione but more generally known as aminophylline, which bears US NIH Compound Identifier 2153. Aminophylline most often comes in base, anhydrous, and dihydrate forms.

UNSPSC 51391610 Aminophylline dihydrate is a Commodity code for a specific pharmaceutical ingredient, yet the recent state and local procurement activity tagged to this code does not reflect purchases of aminophylline dihydrate itself. Instead, the single recent opportunity solicited under this code involves Naloxone and Safe Drug Deactivation Systems—products unrelated to the code's nominal pharmaceutical scope. This mismatch suggests that either the code has been misapplied in the state and local system or that current procurement under this Commodity sits well outside its intended category. State and local buyers using this code do not appear to be purchasing aminophylline dihydrate as a standalone pharmaceutical product at present.

Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026 to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid response deadline was July 26, 2023. The opportunity is the only recent state and local solicitation recorded under this code, and it does not represent typical activity for aminophylline dihydrate procurement. Business development professionals should not rely on this code for meaningful market signal in pharmaceutical ingredient categories, as the recent record shows no material alignment between the Commodity's stated scope and what is actually being bought. Pursue this code only if your firm supplies Naloxone or related emergency drug systems and can establish a direct relationship with Seminole County or other Florida health jurisdictions; the code itself is not a reliable indicator of ongoing aminophylline dihydrate demand in state and local markets.